Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | PIP4K2A | P48426 | 5/20 | 0.35 |
| ▸ | PIP4K2B | P78356 | 4/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | TEAD2 | Q15562 | 2/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.32 |
| ▸ | PIP4K2C | Q8TBX8 | 1/20 | 0.32 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | FLT3 | P36888 | 1/20 | 0.31 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | CYP21A2 | P08686 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2111175 | 1.00 | CYP3A4 (0.39) | CYP3A4PIP4K2APIP4K2BGSK3BTEAD2 | |
| SCHEMBL2110073 | 0.83 | CYP3A4 (0.54) | CYP3A4GSK3BCYP17A1F10FLT3 | |
| SCHEMBL2110072 | 0.83 | CYP3A4 (0.54) | CYP3A4GSK3BCYP17A1F10FLT3 | |
| SCHEMBL2111629 | 0.75 | CYP3A4 (0.41) | CYP3A4PIP4K2APIP4K2BGSK3BTEAD2 | |
| SCHEMBL2111628 | 0.75 | CYP3A4 (0.41) | CYP3A4PIP4K2APIP4K2BGSK3BTEAD2 | |
| SCHEMBL12678927 | 0.74 | CYP3A4 (0.44) | CYP3A4PIP4K2APIP4K2BTEAD2CYP17A1 | |
| SCHEMBL12990815 | 0.73 | CRBN (0.44) | CYP3A4CYP17A1KDM4EMEN1NPC1 | |
| SCHEMBL12991328 | 0.73 | CRBN (0.44) | CYP3A4TEAD2CYP17A1FLT3KDM4E | |
| SCHEMBL1543093 | 0.72 | CYP3A4 (0.53) | CYP3A4PIP4K2APIP4K2BPIP4K2C | |
| SCHEMBL2127309 | 0.72 | CYP3A4 (0.53) | CYP3A4PIP4K2APIP4K2BPIP4K2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2445875-A2 | HETEROCYCLIC ANTIVIRAL COMPOUND | F. Hoffmann-La Roche AG (CH) | 2012-05-02 | — | — | EP | disclosed |
| US-8158631-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2012-04-17 | — | — | US | disclosed |
| US-20100330032-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | CHIN ELBERT | 2010-12-30 | — | — | US | disclosed |
| WO-2010149598-A2 | HETEROCYCLIC ANTIVIRAL COMPOUND | F. HOFFMANN-LA ROCHE AG (CH) | 2010-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330032-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | EIF2AK2, HCCS, RTF2 | CYP3A4 305/4885PIP4K2A 2093/4885PIP4K2B 1707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.